Archived Insight | May 26, 2020

University Business Article on Pandemic and Higher Education

In an article from University Business, Segal's Scott Nostaja gives insight on what issues leaders in higher ed may be grappling with as they steer their institutions into a post-pandemic future.

Read the article.

Questions about this story?

Get in touch with our media team for answers.

Key points from this article

The University Business article provides a high-level look at how institutions of higher education have grappled with the COVID-19 crisis, including:

The priorities of higher ed when the crisis first began unfolding
Why decision-makers have found it difficult to pivot to more long-term, strategic planning about the future
What these same leaders should be doing now to help secure their institution's future

Learn more from our insights

Diverse business colleagues have a meeting

Reporting and Disclosure Guide for Benefit Plans 2025

Segal’s comprehensive Reporting and Disclosure Guide for Benefit Plans is the go-to guide for navigating compliance requirements.

Health, Compliance, Retirement, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical

Read Full Insight

Business Team Discussing New Ideas At The Office

Most SECURE 2.0 Plan Design Options Fully Available for 2025

The Treasury and the IRS have issued guidance for recordkeepers to administer the plan design options SECURE 2.0 made available to DC plan sponsors.

Compliance, Retirement, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Architecture Engineering & Construction

Read Full Insight

Large Group Of Diverse People Wait To See Doctor

New Guidance on Preventive Services

The DOL, HHS and the Treasury have published new guidance on PrEP medication, breast reconstruction, and preventive services claims coding.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Explore all COVID-19 information

We're regularly publishing information on the coronavirus as the situation changes.

Learn More

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.